R Louis, J Shute, S Biagi, L Stanciu, F Marrelli, H Tenor, R Hidi and R Djukanovic
Immunopharmacology Group, University of Southampton, United Kingdom.

We have applied the technique of sputum induction by hypertonic saline in asthmatics and nonatopic control subjects to study an array of indices of airway inflammation believed to be relevant to asthma pathogenesis. Compatible with a central role for eosinophils and mast cells in asthma, sputum of asthmatic subjects contained increased numbers of eosinophils and levels of eosinophil cationic protein (ECP) and mast cell tryptase. Eosinophil numbers, and ECP and histamine levels correlated with the degree of methacholine airways responsiveness, and ECP, tryptase, and histamine correlated with raised concentrations of albumin. Using the micro-Boyden chamber technique eosinophil chemotactic activity was identified only in the sputum from asthmatics. The correlation between the raised levels of total IgA, IL- 8/IgA complexes, and tryptase and the degree of sputum eosinophilia and ECP levels, suggests possible mechanisms for eosinophil chemotaxis and activation in asthma. Row cytometric analysis of sputum lymphocytes showed an increase in CD4+ T cells and T cells expressing intercellular adhesion molecule-1 (ICAM-1) in asthma which, together with the finding of raised levels of soluble ICAM-1 in the sputum, indicates upregulation of this adhesion molecule. Finally, the proportion of CD16+ natural killer (NK) cells was reduced in the sputum of asthmatics. These observations highlight the importance of the airway inflammation in causing asthma and further confirm the usefulness of sputum induction as a tool in asthma research.

This article has been cited by other articles:

				M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri An Investigation of Airway Acidification in Asthma Using Induced Sputum: A Study of Feasibility and Correlation Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 905 - 910. [Abstract] [Full Text] [PDF]

				K. T. Palmer, R. McNeill-Love, J. R. Poole, D. Coggon, A. J. Frew, C. H. Linaker, and J. K. Shute Inflammatory responses to the occupational inhalation of metal fume Eur. Respir. J., February 1, 2006; 27(2): 366 - 373. [Abstract] [Full Text] [PDF]

				M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD Chest, June 1, 2005; 127(6): 1911 - 1918. [Abstract] [Full Text] [PDF]

				G. Dent, C. Hadjicharalambous, T. Yoshikawa, R. L. C. Handy, J. Powell, I. K. Anderson, R. Louis, D. E. Davies, and R. Djukanovic Contribution of Eotaxin-1 to Eosinophil Chemotactic Activity of Moderate and Severe Asthmatic Sputum Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1110 - 1117. [Abstract] [Full Text] [PDF]

				L. J. Marshall, B. Perks, K. Bodey, R. Suri, A. Bush, and J. K. Shute Free Secretory Component from Cystic Fibrosis Sputa Displays the Cystic Fibrosis Glycosylation Phenotype Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 399 - 406. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				M J Leckie, G R Jenkins, J Khan, S J Smith, C Walker, P J Barnes, and T T Hansel Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+) Thorax, January 1, 2003; 58(1): 23 - 29. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: E. Pizzichini, Members of the Working Group:, M.M.M. Pizzichini, R. Leigh, R. Djukanovic, and P.J. Sterk Safety of sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 9S - 18s. [Full Text] [PDF]

				Leader of the Working Group: A. Efthimiadis, A. Sp, Members of the Working Group:, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, M.M.M. Pizzichini, E. Pizzichini, C. Ronchi, F. Van Overveld, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur. Respir. J., July 1, 2002; 20(37_suppl): 19S - 23s. [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				L. J. Marshall, B. Perks, T. Ferkol, and J. K. Shute IL-8 Released Constitutively by Primary Bronchial Epithelial Cells in Culture Forms an Inactive Complex with Secretory Component J. Immunol., September 1, 2001; 167(5): 2816 - 2823. [Abstract] [Full Text] [PDF]

				C. MARGUET, T. P. DEAN, and J. O. WARNER Soluble Intercellular Adhesion Molecule-1 (sICAM-1) and Interferon-Gamma in Bronchoalveolar Lavage Fluid from Children with Airway Diseases Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1016 - 1022. [Abstract] [Full Text]

				M. M. Grunstein, H. Hakonarson, N. Maskeri, C. Kim, and S. Chuang Intrinsic ICAM-1/LFA-1 activation mediates altered responsiveness of atopic asthmatic airway smooth muscle Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1154 - L1163. [Abstract] [Full Text] [PDF]

				R. LOUIS, L. C. K. LAU, A. O. BRON, A. C. ROLDAAN, and M. RADERMECKER The Relationship between Airways Inflammation and Asthma Severity Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 9 - 16. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]